mTOR Inhibitor Treatment of Pancreatic Cancer in a Patient With Peutz-Jeghers Syndrome

被引：68

作者：

Klumpen, Heinz-Josef ^{[1
]}

Queiroz, Karla C. S. ^{[1
]}

Spek, C. Arnold ^{[1
]}

van Noesel, Carel J. M.

Brink, Helmy C.

de Leng, Wendy W. J. ^{[2
]}

de Wilde, Roeland F. ^{[2
]}

Mathus-Vliegen, Elisabeth M. H.

Offerhaus, G. Johan A. ^{[2
]}

Alleman, Maarten A. ^{[3
]}

Westermann, Anneke M.

Richel, Dirk J.

机构：

[1] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands

[2] Univ Med Ctr Utrecht, Utrecht, Netherlands

[3] Isala Hosp, Zwolle, Netherlands

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 06期

关键词：

LKB1; SUPPRESSION; POLYPOSIS; RAPAMYCIN; ARREST; NSCLC; RISK;

D O I：

10.1200/JCO.2010.32.7825

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E150 / E153

页数：4

共 15 条

[1] Very high risk of cancer in familial Peutz-Jeghers syndrome [J].

Giardiello, FM ;

Brensinger, JD ;

Tersmette, AC ;

Goodman, SN ;

Petersen, GM ;

Booker, SV ;

Cruz-Correa, M ;

Offerhaus, JA .

GASTROENTEROLOGY, 2000, 119 (06) :1447-1453

[2] Defining the role of mTOR in cancer [J].

Guertin, David A. ;

Sabatini, David M. .

CANCER CELL, 2007, 12 (01) :9-22

[3] AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy [J].

Hardie, D. Grahame .

NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (10) :774-785

[4] TARGETS FOR CELL-CYCLE ARREST BY THE IMMUNOSUPPRESSANT RAPAMYCIN IN YEAST [J].

HEITMAN, J ;

MOVVA, NR ;

HALL, MN .

SCIENCE, 1991, 253 (5022) :905-909

[5] LKB1; linking cell structure and tumor suppression [J].

Hezel, A. F. ;

Bardeesy, N. .

ONCOGENE, 2008, 27 (55) :6908-6919

[6] Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase [J].

Jenne, DE ;

Reimann, H ;

Nezu, J ;

Friedel, W ;

Loff, S ;

Jeschke, R ;

Müller, D ;

Back, W ;

Zimmer, M .

NATURE GENETICS, 1998, 18 (01) :38-44

[7] LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis [J].

Katajisto, Pekka ;

Vaahtomeri, Kari ;

Ekman, Niklas ;

Ventela, Eeva ;

Ristimaki, Ari ;

Bardeesy, Nabeel ;

Feil, Robert ;

DePinho, Ronald A. ;

Makela, Tomi P. .

NATURE GENETICS, 2008, 40 (04) :455-459

[8] LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition [J].

Mahoney, C. L. ;

Choudhury, B. ;

Davies, H. ;

Edkins, S. ;

Greenman, C. ;

van Haaften, G. ;

Mironenko, T. ;

Santarius, T. ;

Stevens, C. ;

Stratton, M. R. ;

Futreal, P. A. .

BRITISH JOURNAL OF CANCER, 2009, 100 (02) :370-375

[9] LKB1 Haploinsufficiency Cooperates With Kras to Promote Pancreatic Cancer Through Suppression of p21-Dependent Growth Arrest [J].

Morton, Jennifer P. ;

Jamieson, Nigel B. ;

Karim, Saadia A. ;

Athineos, Dimitris ;

Ridgway, Rachel A. ;

Nixon, Colin ;

Mckay, Colin J. ;

Carter, Ross ;

Brunton, Valerie G. ;

Frame, Margaret C. ;

Ashworth, Alan ;

Oien, Karin A. ;

Evans, T. R. Jeffry ;

Sansom, Owen J. .

GASTROENTEROLOGY, 2010, 139 (02) :586-597

[10] mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome [J].

Shackelford, David B. ;

Vasquez, Debbie S. ;

Corbeil, Jacqueline ;

Wu, Shulin ;

Leblanc, Mathias ;

Wu, Chin-Lee ;

Vera, David R. ;

Shaw, Reuben J. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (27) :11137-11142

← 1 2 →